CSIMarket
 
Unity Biotechnology Inc   (NASDAQ: UBX)
 

Unity Biotechnology Inc's Customers Performance

UBX



 
UBX's Source of Revenues

List of UBX Customers




for the same period Unity Biotechnology Inc

List of UBX Customers





Unity Biotechnology Inc's Comment on Sales, Marketing and Customers





  News about Unity Biotechnology Inc Contracts

A Bold Leap Forward: UNITY Biotechnology Begins Phase 2 Trials of Vision impairment Drug UBX1325 with Promising Outlook for 2024


UNITY Biotechnology has marked a significant stride in its ambitious endeavor to combat vision impairment. The company, renowned for developing therapeutics that potentially halt, slow, or reverse age-associated diseases, announced the initiation of patient dosing in Phase 2 of their ASPIRE study. The trial focuses on evaluating the efficacy of UBX1325, UNITY s transformative drug, in treating Diabetic Macular Edema (DME). The biotechnology giant expects to release the preliminary 16-week data by the fourth quarter of 2024.
The ASPIRE trial represents a crucial step in our understanding of how cutting-edge biotechnology can transform lives, especially for DME patients. Characterized by fluid accumul...












UBX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Unity Biotechnology Inc 3.38 0.00 -27.50 75
SUBTOTAL 0.00 0.00 0.00 -

Sources: Unity Biotechnology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Unity Biotechnology Inc’s corporate clients.
For your research, we’ve provided 9 tables on Unity Biotechnology Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.